New Health and Medicine Study Results Reported from R.J. Willke et al (Review of Recent US Value Frameworks-A Health Economics Approach: An ISPOR…

Investment Weekly News

New Health and Medicine Study Results Reported from R.J. Willke et al (Review of Recent US Value Frameworks-A Health Economics Approach: An ISPOR Special Task Force Report [6])

By a News Reporter-Staff News Editor at Investment Weekly News -- Fresh data on Health and Medicine are presented in a new report. According to news reporting from Lawrenceville, New Jersey, by VerticalNews journalists, research stated, "The sixth section of our Special Task Force (STF) report reviews and comments on recent US-oriented value assessment frameworks, specifically those published by the American College of Cardiology/American Heart Association, the Institute for Clinical and Economic Research, the American Society of Clinical Oncology, the National Comprehensive Cancer Network, and the Memorial Sloan Kettering Cancer Center. We review published commentaries that address the validity, reliability, and conceptual underpinnings of these frameworks."

The news correspondents obtained a quote from the research, "We find common themes of critique regarding the strengths and limitations across frameworks. Particular shortcomings of some frameworks pose greater threats to their face validity and utility compared with others. The most significant limitations include lack of clear perspective (e.g., patient vs. health plan) and poor transparency in accounting for costs and benefits. We then review how each framework adheres to core STF recommendations, with particular emphasis on whether the framework can be used to support coverage decisions by health insurers, and whether it adheres to core principles of cost-effectiveness analysis. The Institute for Clinical and Economic Research framework most closely adheres to core STF recommendations. Others have significant limitations that vary widely from framework to framework. We also review how the frameworks follow STF recommendations for addressing potentially relevant issues beyond cost-effectiveness analysis - for example, equity in resource allocation and patient heterogeneity. Finally, we review whether and how each framework uses value thresholds and addresses affordability concerns."

According to the news reporters, the research concluded: "We conclude with suggestions for further research, particularly in the areas of testing the measurement and use of novel elements of value and deliberative processes."

For more information on this research see: Review of Recent US Value Frameworks-A Health Economics Approach: An ISPOR Special Task Force Report [6]. Value in Health, 2018;21(2):155-160. Value in Health can be contacted at: Elsevier Science Inc, 360 Park Ave South, New York, NY 10010-1710, USA. (Elsevier - www.elsevier.com; Value in Health - www.journals.elsevier.com/value-in-health/)

Our news journalists report that additional information may be obtained by contacting R.J. Willke, Int Soc Pharmacoecon & Outcomes Res, Lawrenceville, NJ 08648, United States. Additional authors for this research include P.J. Neumann, L.P. Garrison and S.D. Ramsey.

Keywords for this news article include: Lawrenceville, New Jersey, United States, North and Central America, Health and Medicine, Finance and Investment.